Is 20/20 Biolabs, Inc. (AIDX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 2.9% / 30% | 6.2% / 30% | 0.5% / 30% | 4.53% / 5% | ✓ HALAL |
| DJIM | 2.9% / 33% | 6.2% / 33% | 0.5% / 33% | 4.53% / 5% | ✓ HALAL |
| MSCI | 23.4% / 33% | 49.8% / 33% | 3.8% / 33% | 4.53% / 5% | ✗ NOT HALAL |
| S&P | 2.9% / 33% | 6.2% / 33% | 0.5% / 33% | 4.53% / 5% | ✓ HALAL |
| FTSE | 23.4% / 33% | 49.8% / 33% | 3.8% / 50% | 4.53% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 32.1% | |
| Operating Margin | -191.4% | |
| Net Margin | -159.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$3M |
| Free Cash Flow | -$3M |
| Total Debt | $839,550 |
| Debt-to-Equity | 1069.4 |
| Current Ratio | 0.8 |
| Total Assets | $4M |
Price & Trading
| Last Close | $1.73 |
| 50-Day MA | $4.40 |
| 200-Day MA | $4.40 |
| Avg Volume | 362K |
| Beta | -0.4 |
|
52-Week Range
$1.51
| |
About 20/20 Biolabs, Inc. (AIDX)
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Purification Calculator
As a halal stock with 4.53% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is 20/20 Biolabs, Inc. (AIDX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), 20/20 Biolabs, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is 20/20 Biolabs, Inc.'s debt ratio?
20/20 Biolabs, Inc.'s debt ratio is 2.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 23.4%.
Does 20/20 Biolabs, Inc. require dividend purification?
Yes, 20/20 Biolabs, Inc. has an impermissible income ratio of 4.53%, which means 4.53% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are 20/20 Biolabs, Inc.'s key financial metrics?
20/20 Biolabs, Inc. has a market capitalization of $19M, and revenue of $2M. The company maintains a gross margin of 32.1% and a net margin of -159.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.